March 16, 2026

Scaling Vision Innovation

Rob Scott, Vice President of Intraocular Devices R&D, Alcon

The Ophthalmologist

March 16, 2026

Redefining Eye Care Impact

Elizabeth Yeu, MD, Chief Medical Officer, Tarsus Pharmaceuticals

The Ophthalmologist

March 13, 2026

Family History and Early Screening: Detecting Brain Aneurysms Before They Rupture

An aneurysm can develop anywhere in the brain’s network of blood vessels. It occurs when a section of an artery wall weakens, causing the blood flowing through the area to put additional pressure on the artery wall.

Baptist Health South Florida

March 13, 2026

A New Era in Alzheimer’s Care: The Shift Toward Early Detection and Prevention

The future of Alzheimer’s care holds incredible promise. Recently, leaders from medicine, government, and the pharmaceutical industry gathered to discuss this exact topic.

Baptist Health South Florida

March 13, 2026

Building Quality into Advanced Therapies from Day One

Why early, risk-based thinking is critical in cell and gene therapy development

The Medicine Maker

March 13, 2026

Hydrus®: Designed with Purpose

Professor Norbert Pfeiffer explores the features and benefits of the Hydrus® Microstent

The Ophthalmologist

March 13, 2026

Engineering Safer Editors for Cystic Fibrosis Mutations 

Modified APOBEC3G editors improve CRISPR base-editing specificity and reduce bystander mutations in human cells

The Medicine Maker

March 13, 2026

Rayner Expands US Cataract Platform with Anikavisc Acquisition

Strengthens Rayner’s US cataract portfolio with a fully bundled OVD, IOL and phaco offering

The Ophthalmologist

March 12, 2026

$5 Million Grant from Elaine and Eduardo Saverin Foundation to Benefit Baptist Health Miami Neuroscience Institute

Baptist Health Foundation announced that it has received a $5 million grant from the Elaine and Eduardo Saverin Foundation benefiting Baptist Health Miami Neuroscience Institute.

Baptist Health South Florida

March 12, 2026

Genes Predict Bowel Disease Severity

Large study suggests genetic risk scores could help doctors identify patients who need closer monitoring and earlier treatment

The Pathologist